Safety Study of a Melanoma Vaccine (GVAX) With or Without Cyclophosphamide in Patients With Surgically Resected Melanoma

Clinical Trial ID NCT01435499

PubWeight™ 5.68‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01435499

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer. Nat Rev Clin Oncol 2013 2.64
2 Trial watch: Chemotherapy with immunogenic cell death inducers. Oncoimmunology 2012 1.33
3 Combining immunotherapy with oncogene-targeted therapy: a new road for melanoma treatment. Front Immunol 2015 1.04
4 Safety and immunologic correlates of Melanoma GVAX, a GM-CSF secreting allogeneic melanoma cell vaccine administered in the adjuvant setting. J Transl Med 2015 0.80
Next 100